Literature DB >> 28332735

Non-Hodgkin lymphoma in South East Asia: An analysis of the histopathology, clinical features, and survival from Thailand.

Tanin Intragumtornchai1, Udomsak Bunworasate1, Kitsada Wudhikarn1, Arnuparp Lekhakula2, Jakrawadi Julamanee2, Kanchana Chansung3, Chittima Sirijerachai3, Lalita Norasetthada4, Weerasak Nawarawong4, Archrob Khuhapinant5, Noppadol Siritanaratanakul5, Tontanai Numbenjapon6, Kannadit Prayongratana6, Suporn Chuncharunee7, Pimjai Niparuck7, Tawatchai Suwanban8, Nongluk Kanitsap9, Somchai Wongkhantee10, Rutchanid Pornvipavee11, Peerapon Wong12, Nisa Makruasi13, Pongsak Wannakrairot14, Thamathorn Assanasen14, Sanya Sukpanichnant15, Paisarn Boonsakan16, Wasana Kanoksil16, Charin Ya-In17, Kanita Kayasut18, Winyu Mitranun18, Naree Warnnissorn19.   

Abstract

Systemic reports on the descriptive epidemiology of non-Hodgkin lymphoma (NHL) from Southeast Asia are scarce. A nationwide multi-institutional registry was conducted to compare the histopathology, clinical features, and survival of Thai adult patients with NHL using large registries, especially those from Far East Asia (FEA). Using a web-based registry system, 13 major medical centers from the 4 geographic regions of Thailand prospectively collected, from 2007 to 2014, the diagnostic pathology, according to the World Health Organization classification, 2008, clinical features and survival of 4056 patients who were newly diagnosed with NHL. The median age of the patients was 56 years (range, 16-99 years). The male-to-female ratio was 1.3:1. From the total of 4056 patients, T/NK-cell lymphoma (TNKCL) accounted for 12.6% of cases, and 5.1% had human immunodeficiency virus-associated lymphoma. The four leading histological subtypes were diffuse large B-cell lymphoma, not otherwise specified (58.1%); follicular lymphoma (5.6%); extranodal mucosa-associated lymphoid tissue lymphoma (5.2%); and peripheral T-cell lymphoma, not otherwise specified (4.0%). With a median follow-up duration of 46.1 months, the median overall survival of B-cell NHL was significantly longer than that of patients with TNKCL (76.5 vs 28.8 months, P = .0001). Compared to FEA, the Thai registry had an approximately one-half lower relative frequency of TNKCL; the prevalence of extranodal mucosa-associated lymphoid tissue lymphoma was much lower than in Korea, and the frequency of extranodal TNKCL, nasal type, was strikingly low compared to China. It is concluded that while the median age of Thai patients with NHL was approximately a decade younger than for Caucasians, the long-term survival rates for most histological subtypes were comparable. While the histological distribution generally complied with the characteristic Asian features, some differences from FEA were observed.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Thailand; descriptive epidemiology; non-Hodgkin lymphoma; pathology; survival

Mesh:

Year:  2017        PMID: 28332735     DOI: 10.1002/hon.2392

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


  7 in total

1.  Exploring health-related quality of life among non-Hodgkin's lymphoma survivors after completion of primary treatment: a cross-sectional study in Thailand.

Authors:  Pichitra Lekdamrongkul; Kanaungnit Pongthavornkamol; Alex Molassiotis; Aurawamon Sriyuktasuth; Noppadol Siritanaratkul; Natkamol Chansatitporn
Journal:  Support Care Cancer       Date:  2021-04-28       Impact factor: 3.603

2.  Clinicopathological study and outcomes of primary extranodal lymphoma.

Authors:  Nichapa Nanthakwang; Ekarat Rattarittamrong; Thanawat Rattanathammethee; Chatree Chai-Adisaksopha; Adisak Tantiworawit; Lalita Norrasethada; Charin Ya-In
Journal:  Hematol Rep       Date:  2019-11-29

Review 3.  Estimating the global burden of Epstein-Barr virus-related cancers.

Authors:  Yide Wong; Michael T Meehan; Scott R Burrows; Denise L Doolan; John J Miles
Journal:  J Cancer Res Clin Oncol       Date:  2021-10-27       Impact factor: 4.553

4.  MUM1 Expression versus Hans Algorithm to Predict Prognosis in Indonesian Diffuse Large B-Cell Lymphoma Patients Receiving R-CHOP.

Authors:  Cosphiadi Irawan; Martha Iskandar; Agnes Stephanie Harahap; Cleopas Martin Rumende; Maria Francisca Ham
Journal:  Cancer Manag Res       Date:  2022-03-01       Impact factor: 3.989

5.  Investigation of the incidence trend of follicular lymphoma from 2008 to 2017 in Taiwan and the United States using population-based data.

Authors:  Yu-Chieh Su; Brian Chih-Hung Chiu; Hung-Ju Li; Wen-Chi Yang; Tsai-Yun Chen; Su-Peng Yeh; Ming-Chung Wang; Wen-Tsung Huang; Ming-Yang Lee; Sheng-Fung Lin
Journal:  PLoS One       Date:  2022-03-17       Impact factor: 3.240

6.  Subtype distribution of lymphomas in northwestern Iran: a retrospective analysis of 659 cases according to World Health Organization classification.

Authors:  Javad Jalili; Amir Vahedi; Amin Danandehmehr; Parya Aynechi; Ali Esfahani; Yousef Roosta; Hooman Nateghian; Amirhosein Ghafouri Asbagh; Fateme Hajihoseinlou
Journal:  BMC Cancer       Date:  2022-10-12       Impact factor: 4.638

Review 7.  How to Sequence Therapies in Peripheral T Cell Lymphoma.

Authors:  Kitsada Wudhikarn; N Nora Bennani
Journal:  Curr Treat Options Oncol       Date:  2021-07-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.